Gene · 259197
Papers4,252
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,252
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade. | J Exp Clin Cancer Res | 2025 | 40877861 | PubTator, text mining | PubMed |
| A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cells. | BMC Biotechnol | 2025 | 40866992 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
| SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults. | Nat Commun | 2025 | 40849415 | PubTator, text mining | PubMed |
| Identification of Plasma Biomarkers for B7 Family Members Associated With Primary Sjögren's Syndrome. | Immun Inflamm Dis | 2025 | 40844039 | PubTator, text mining | PubMed |
| The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS. | Nat Commun | 2025 | 40841539 | PubTator, text mining | PubMed |
| Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside. | Stem Cell Res Ther | 2025 | 40830985 | PubTator, text mining | PubMed |
| The Activity of EGFR CAR NK and CAR T Cells against EGFR Inhibitor-Resistant NSCLC and Drug-Tolerant Persister Cells. | Clin Cancer Res | 2025 | 40828417 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir. | J Transl Med | 2025 | 40804634 | PubTator, text mining | PubMed |
| Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer. | BMC Cancer | 2025 | 40783506 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis. | Sci Rep | 2025 | 40744980 | PubTator, text mining | PubMed |
| VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function. | Cancer Immunol Immunother | 2025 | 40736709 | PubTator, text mining | PubMed |
| Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies. | Regen Ther | 2025 | 40704043 | PubTator, text mining | PubMed |
| An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing. | J Leukoc Biol | 2025 | 40694640 | PubTator, text mining | PubMed |
| NKp30: A Key Membrane Molecule in the Fight Against Cancer and Infection. | FASEB J | 2025 | 40678939 | PubTator, text mining | PubMed |
| Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models. | Gut Liver | 2025 | 40626281 | PubTator, text mining | PubMed |
| A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors. | Front Immunol | 2025 | 40607388 | PubTator, text mining | PubMed |
| The Rise of Mechanobiology for Advanced Cell Engineering and Manufacturing. | Adv Mater | 2025 | 40576525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259197/papers?page=6